Harvard Bioscience, Inc.
USD6.46
+0.06 (+0.94%)
CEO
John Duke
IPO Date
2001-03-19
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Country
US
Open
$6.54
Prev. Close
$6.40
Day Low
$6.31
Day High
$6.69
52W Low
$3.70
52W High
$9.40
Market Cap
$0.03B
Volume
0.03M
| 5,000 |
| $5.00 |
| 23 Mar 2026 | Duke John D | director, officer: Chief Executive Officer | A-Award | Acquired | 75,000 | $0.00 |
| 18 Mar 2026 | DENELSKY STEPHEN J | director | P-Purchase | Acquired | 10,000 | $4.87 |
| 18 Mar 2026 | Snider William | director | P-Purchase | Acquired | 12,525 | $4.99 |
| 18 Mar 2026 | Snider William | director | P-Purchase | Acquired | 8,475 | $4.85 |
| 17 Mar 2026 | Duke John D | director, officer: Chief Executive Officer | P-Purchase | Acquired | 5,000 | $5.01 |
| 30 Dec 2025 | Snider William | director | A-Award | Acquired | 110,000 | $0.00 |
| 30 Dec 2025 | Snider William | director | Disposed | 600,000 | $0.50 |
| 7 Oct 2025 | DENELSKY STEPHEN J | director | A-Award | Acquired | 110,000 | $0.00 |